These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

11241 related items for PubMed ID: 1296812

  • 1. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
    Lemieux P, Pagé M, Noël C.
    In Vivo; 1992; 6(6):621-7. PubMed ID: 1296812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
    Szabó I, Manea M, Orbán E, Csámpai A, Bosze S, Szabó R, Tejeda M, Gaál D, Kapuvári B, Przybylski M, Hudecz F, Mezo G.
    Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.
    Feldman NB, Kiselev SM, Gukasova NV, Posypanova GA, Lutsenko SV, Severin SE.
    Biochemistry (Mosc); 2000 Aug; 65(8):967-71. PubMed ID: 11002192
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.
    Fu JY, Blatchford DR, Tetley L, Dufès C.
    J Control Release; 2009 Dec 03; 140(2):95-9. PubMed ID: 19709637
    [Abstract] [Full Text] [Related]

  • 10. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
    Marchini S, Damia G, Broggini M, Pennella G, Ripamonti M, Marsiglio A, Geroni C.
    Cancer Res; 2001 Mar 01; 61(5):1991-5. PubMed ID: 11280757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.
    Hornung RL, Pearson JW, Beckwith M, Longo DL.
    Cancer Res; 1992 Jan 01; 52(1):101-7. PubMed ID: 1727368
    [Abstract] [Full Text] [Related]

  • 13. Synergistic in vitro and in vivo anti-tumor effect of daunomycin-anti-96-kDa melanoma-associated antigen monoclonal antibody CL 207 conjugate and recombinant IFN-gamma.
    Matsui M, Nakanishi T, Noguchi T, Ferrone S.
    J Immunol; 1988 Aug 15; 141(4):1410-7. PubMed ID: 3135332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY, Liu C, Hong MH, Zhu SJ, Pei YY.
    Bioconjug Chem; 2007 Aug 15; 18(1):41-9. PubMed ID: 17226956
    [Abstract] [Full Text] [Related]

  • 16. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS.
    Cancer Res; 1990 Oct 01; 50(19):6295-301. PubMed ID: 2400993
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.
    Akiyama N, Hijikata M, Kobayashi A, Yamori T, Tsuruo T, Natori S.
    Anticancer Res; 2000 Oct 01; 20(1A):357-62. PubMed ID: 10769680
    [Abstract] [Full Text] [Related]

  • 18. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III.
    Park YS, Hakomori S, Kawa S, Ruan F, Igarashi Y.
    Cancer Res; 1994 Apr 15; 54(8):2213-7. PubMed ID: 8174128
    [Abstract] [Full Text] [Related]

  • 19. [Transferrin conjugates in the anticancer therapy].
    Lubgan D, Marczak A, Distel L, Jóźwiak Z.
    Postepy Biochem; 2006 Apr 15; 52(1):72-9. PubMed ID: 16869304
    [Abstract] [Full Text] [Related]

  • 20. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo.
    Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X.
    Int J Oncol; 2003 Jan 15; 22(1):93-8. PubMed ID: 12469190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 563.